Anne Favret, M.D.

VCS Physicians

Anne Favret, M.D. Headshot

Caring for women with breast cancer is a privilege. I am tasked with determining the very best treatment for each individual patient and working collaboratively with them on their journey.

Primary Location:

Fairfax Office
Position

Medical Oncologist

Board Certification

Medical Oncology

Fellowship

Stanford University, Medical Oncology

Internship

Georgetown University

Residency

Georgetown University

Medical School

Temple University

College

Catholic University

Anne Favret, M.D. received her medical degree from Temple University and completed her internship and residency at Georgetown University Hospital. During her fellowship at Stanford University, she developed an interest in clinical research for breast cancer and has published several review articles, original research papers and a book chapter in the area of breast cancer management. Dr. Favret has also regularly spoken within the community and to news sources on the subject of breast cancer. In 2014, she was featured in Forbesmagazine for her expertise in breast cancer detection methods.

Dr. Favret is a member of the American Society of Clinical Oncology and stays active with tumor boards and local support groups. Having made patient care a top priority, she has received several awards throughout her career, including Top Doctor and Best Doctor honors in Washingtonian magazine, Virginia Living Magazine, and the Washington Post. Dr. Favret serves on the Executive Committee and is the Co-director of Breast Research for Virginia Cancer Specialists. She also serves on the Breast Committee for US Oncology.

Dr. Favret enjoys spending time with her family, including her three children. Her leisure time is spent cooking, running, entertaining, and going to the beach.

 


 

Physician Publications

July 29, 2016

Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.

Read More
November 1, 2015

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

Read More
September 3, 2013

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study

Read More

More Publications by Anne Favret, M.D.

February 2, 2013

Expert Insight: Genomic Variants Used To Further Stratify Risk in Breast Cancer

Read More
November 1, 2009

Dose intensity in early-stage breast cancer: a community practice experience.

Read More
April 1, 2007

HER2-positive advanced breast cancer

Read More
September 1, 1999

Multidisciplinary Management of Locally Advanced Breast Cancer

Read More

Primary Location

Fairfax Office Office

Fairfax Office

Learn More

Other Locations

Awards

November 15, 2018
Northern Virginia Magazine Top Doctors 2018

Northern Virginia Magazine Top Doctors 2018


November 15, 2018
Virginia Living Magazine Top Doctors 2018

Top Doctors Virginia Living Magazine 2018


September 9, 2016
Washingtonian Magazine

Washingtonian Top Doctor 2016


December 31, 2013
Washingtonian Magazine

Washingtonian Top Doctor 2015


December 31, 2013
Virginia Living Magazine

Top Doctor 2014


May 31, 2013
Super Doctors

Washington Post Super Doctors 2013


January 31, 2013
Northern Virginia Magazine

Top Doctor 2013